Yes, Tricor is often prescribed alongside a statin to address persistent high triglycerides. However, the combination increases the risk of muscle-related side effects, so the prescribing clinician should select a statin with a lower interaction potential and monitor muscle enzymes regularly.
A mild rash may resolve on its own, but any skin reaction that is widespread, itchy, or accompanied by fever should be reported to a healthcare professional promptly. Discontinuation may be necessary if the rash is judged to be drug-related.
For patients with a creatinine clearance of 30-50 mL/min, Tricor can be used at the lower 160 mg dose with careful monitoring of renal function. Doses above 160 mg are generally avoided in this group.
Most patients notice a reduction in triglycerides within 2-4 weeks, with the greatest effect typically observed after 8-12 weeks of continuous therapy.
Yes, but keep the medication in its original labeled container, carry a copy of the prescription, and be aware of any country-specific import restrictions on prescription drugs. The UK’s MHRA permits personal use quantities for travel.
Fish oil also lowers triglycerides and may have additive effects, but it generally does not cause harmful interactions. Nevertheless, inform your prescriber about any supplements you are taking to ensure coordinated care.
Tricor is designed to lower triglycerides and raise HDL-C; it may modestly lower LDL-C. Your lipid panel will reflect these changes, which your clinician will interpret in the context of overall cardiovascular risk.
Fasting is recommended for accurate triglyceride measurement, regardless of medication. Continue taking Tricor as prescribed; do not skip doses before the test.
Fenofibrate tablets are formulated for whole-tablet administration. Crushing or splitting may alter absorption and is not advised unless a specialist formulation is provided.
Pricing varies by pharmacy and NHS prescription status. The 200 mg tablet is typically more expensive per tablet but may reduce the total number of tablets needed for a given dose. For exact costs, consult your local pharmacy or NHS prescription service.
Tricor is a prescription medication that contains fenofibrate as its active component. Fenofibrate belongs to the cholesterol-lowering class of drugs known as fibrates. The product is supplied as a solid oral pill and is available in the United Kingdom in two strengths: 160 mg and 200 mg. Tricor is marketed under a licence issued by the Medicines and Healthcare products Regulatory Agency (MHRA) and is prescribed for the management of certain lipid disorders.
Fenofibrate activates peroxisome proliferator-activated receptor-α (PPAR-α), a nuclear transcription factor that regulates genes involved in lipid metabolism. By stimulating PPAR-α, Tricor:
The therapeutic effect typically begins within 1-2 weeks, with maximal lipid changes observed after 4-8 weeks of continuous therapy. Fenofibrate is well absorbed after oral administration; food increases its bioavailability modestly, but the drug can be taken with or without meals. The compound is extensively metabolised in the liver and excreted primarily via the bile.
Tricor is approved by the MHRA for the treatment of adults with:
The medication is intended for patients who are already following a low-fat diet and who may also be receiving statins, provided that combined therapy is deemed appropriate by a prescriber. Tricor is not indicated for primary prevention of cardiovascular disease in patients with normal lipid profiles.
If a patient takes other medications, they should discuss the full list with their prescriber, as additional interactions may exist.
Standard dosing:
Adults typically start with one 160 mg tablet taken once daily.
If lipid goals are not achieved, the dose may be increased to 200 mg once daily, provided renal function is adequate.
Administration:
Swallow the tablet whole with a glass of water.
The pill can be taken with or without meals; consistent timing each day helps maintain steady drug levels.
Renal or hepatic impairment:
For creatinine clearance 30-50 mL/min, consider starting at 160 mg and reassessing after 4 weeks.
In moderate hepatic disease, avoid initiating therapy; if already on Tricor, discontinue and monitor liver tests.
Missed dose:
Take the missed tablet as soon as remembered, unless it is near the time of the next scheduled dose. Do not double the dose.
Overdose:
Symptoms may include nausea, vomiting, abdominal pain, and dizziness. Seek emergency medical care; supportive care and activated charcoal are standard measures.
Discontinuation:
Tricor does not require tapering. Stop abruptly under medical advice, but continue regular lipid monitoring to assess the need for alternative therapy.
This article provides educational information about Tricor and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
